Navigation Links
ValGenesis, Inc., the Leading Provider of Validation Lifecycle Management Solutions to Regulated Life Science Companies, Today Announced Support for EMC Documentum v.6.5

FREMONT, Calif., Sept. 3 /PRNewswire/ -- ValGenesis, Inc. today announced the worldwide availability of the vDoc360 connector for EMC Documentum v.6.5 to increase enterprise productivity specifically for regulated Pharmaceuticals, Biotech and Medical Devices companies. The vDoc360 seamlessly integrates ValGenesis with the EMC Documentum v.6.5 Server. This integration offers Documentum customers an end-to-end secured, 100% paperless validation lifecycle management solution and central storage of validation documents provided by these two complementary technologies.

This offering will seamlessly provide global access, retrieval and storage of corporate validation data and documents generated by ValGenesis within EMC Documentum v.6.5 Server. This helps to leverage real-time reporting and the robust search functionality of Documentum Server for validation data and documents.

With the vDoc360 connector for EMC Documentum, customers can extend Documentum's access control and audit capabilities to corporate validation data and documents. Furthermore, document management staff can apply federated retention policies to unify management practices across all documents and record types throughout their organizations, ensuring consistent compliance to regulatory requirements.

"Many Life Sciences companies use Documentum for document management and want the flexibility to leverage this investment. ValGenesis continues to offer state-of-the-art ValGenesis software and now allows customers to use Documentum as the central repository for validation data and documents throughout the enterprise with this integration. ValGenesis also interfaces with many other systems, including automated test engines, to leverage the power of these test engines for validation requirements. The interface with Documentum facilitates the storage of the test data and documents generated by test engines in Documentum through configurable workflow provided by ValGenesis. ValGenesis offers Documentum users strengthened return on investment and additional usability, functionality and productivity," said Siva Samy, Ph.D., ValGenesis Chief Product Strategist.

About ValGenesis

ValGenesis offers an innovative software platform that serves as the foundation for compliance-based validation life cycle management in regulated companies by enabling a 100% paperless validation process. ValGenesis is the first Enterprise application to automate the validation lifecycle and to provide 360-degree visibility to the corporate validation process. ValGenesis is designed to fully conform to FDA 21 CFR Part 11 compliance requirements. Through an industry peer review committee, the Parenteral Drug Association (PDA) awarded ValGenesis the prestigious New Innovative Technology award.

    For more information, contact:

    Mike Beaudro, 510-445-0505,

This release was issued through eReleases(TM). For more information, visit

SOURCE ValGenesis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ValGenesis, Inc. Announces Integration of ValGenesis Solution with Microsoft SharePoint Server
2. ValGenesis, Inc. Announces Worldwide Release of Validation Life Cycle Management System - ValGenesis 2.0
3. BioStorage Technologies, Inc., Welcomes Catherine Michael as Global Head of Sample Management Operations
4. Sigma-Aldrich Acquires ChemNavigator, Inc., to Provide Researchers With Industry-Leading Chemical Compound Selection and Procurement Services
5. avVaa World Health Care Products, Inc. Signs Agreement with 3PL Worldwide, Inc., for Order Management & Fulfillment for avVaas Product
6. BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales
7. Buehler Motor, Inc., Significantly Expands Customer and Partner Support in North America
8. Providence-Based NABsys, Inc., Announces $4 Million Equity Financing
9. CRO Acquisition Seen Boosting Activity, Positioning ASG, Inc., for New Growth in Q2
10. iZumi Bio, Inc., Appoints John Walker as Chief Executive Officer
11. Helsinn Announces the Acquisition of Sapphire Therapeutics Inc., USA to Establish Helsinn Therapeutics (US) Inc.
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... be speaking at the following conference, and invited investors ... York, NY      Tuesday, December 1, 2015 at ... York, NY      Tuesday, December 1, 2015 at ... Healthcare Conference, New York, NY ...
(Date:11/24/2015)... ... November 24, 2015 , ... Copper ... unless it is bound to proteins, copper is also toxic to cells. With ... Worcester Polytechnic Institute (WPI) will conduct a systematic study of copper in the ...
(Date:11/24/2015)... RALEIGH, N.C. , Nov. 24, 2015  Clintrax Global, Inc., ... Raleigh, North Carolina , today announced that the company has ... earnings represented a 391% quarter on quarter growth posted for Q3 ... Kingdom and Mexico , with the ... place in December 2015. --> United Kingdom ...
(Date:11/24/2015)... ... 24, 2015 , ... The Academy of Model Aeronautics (AMA), led by its ... as Multirotor Grand Prix, to represent the First–Person View (FPV) racing community. , FPV ... embraced this type of racing and several new model aviation pilots have joined the ...
Breaking Biology Technology:
(Date:11/19/2015)... , Nov. 19, 2015  Although some 350 companies ... dominated by a few companies, according to Kalorama Information. These ... 51% of the market share of the 6.1 billion-dollar ... The World Market for Molecular Diagnostic s .    ... market is still controlled by one company and only ...
(Date:11/17/2015)... Paris , qui s,est tenu ... Paris , qui s,est tenu du 17 au ... l,innovation biométrique, a inventé le premier scanner couplé, qui ... même surface de balayage. Jusqu,ici, deux scanners étaient nécessaires, ... digitales. Désormais, un seul scanner est en mesure de ...
(Date:11/12/2015)...  A golden retriever that stayed healthy despite having ... provided a new lead for treating this muscle-wasting disorder, ... of MIT and Harvard and the University of São ... Cell, pinpoints a protective gene that boosts ... The Boston Children,s lab of Lou Kunkel , ...
Breaking Biology News(10 mins):